SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001161697-09-000769
Filing Date
2009-08-14
Accepted
2009-08-14 09:05:40
Documents
6
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR 06-30-2009 lotus_form10-q.htm 10-Q 1070211
2 GRAPHIC img1.jpg GRAPHIC 19669
3 RULE 13A-14(A)/ 15D-14(A) CERTIFICATION OF CEO ex311.htm EX-31 7141
4 RULE 13A-14(A)/ 15D-14(A) CERTIFICATION OF CFO ex312.htm EX-31 7152
5 SECTION 1350 CERTIFICATION OF CEO ex321.htm EX-32 3460
6 SECTION 1350 CERTIFICATION OF CFO ex322.htm EX-32 3472
  Complete submission text file 0001161697-09-000769.txt   1120232
Mailing Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071
Business Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071 86-10-63899868
Lotus Pharmaceuticals, Inc. (Filer) CIK: 0001292087 (see all company filings)

IRS No.: 200507918 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32581 | Film No.: 091012432
SIC: 2834 Pharmaceutical Preparations